facebook
twitter
rss
account
search
search
 

Alzheimer's drug reduces amyloid levels

Oct. 10, 2011 at 11:29 PM   |   Comments

BASEL, Switzerland, Oct. 10 (UPI) -- The medication gantenerumab appeared to reduce brain amyloid levels in patients with Alzheimer's disease in a preliminary stuidy, Swiss researchers say.

Dr. Susanne Ostrowitzki of the F. Hoffmann-La Roche Ltd., Neuroscience in Basel, Switzerland, and colleagues said the study involved study subjects, who had mild-to-moderate Alzheimer's disease, at three university medical centers.

Two consecutive groups of patients were randomized to receive two to seven infusions of intravenous gantenerumab -- 60 mg or 200 mg -- or placebo every four weeks.

Additionally, brain tissue from two patients who had Alzheimer's disease -- tissue obtained during tumor surgery -- was examined.

"Our study demonstrates that two to seven months of treatment with gantenerumab led to dose-dependent amyloid reduction in the brains of patients with Alzheimer's disease," the study authors said in a statement. "Additionally, our findings in the placebo-treated patients support previous reports indicating that amyloid load continues to increase in many patients with mild-to-moderate Alzheimer's disease."

The authors suggest the treatment may work through an "effector cell-mediated mechanism of action" but it is unclear whether any reduction in brain amyloid level will translate into patient improvement.

"A phase two clinical trial is under way to investigate whether a clinical benefit can be achieved in gantenerumab-treated patients with early symptoms of Alzheimer's disease," the researchers said.

The findings are published in Online First by Archives of Neurology.

© 2011 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Most Popular
1
CDC: Get your flu vaccine CDC: Get your flu vaccine
2
Study shows one dose of antidepressants changes the brain Study shows one dose of antidepressants changes the brain
3
16 U.S. food makers surpass calorie-counting pledge 16 U.S. food makers surpass calorie-counting pledge
4
Morning exercise helps calm ADHD symptoms in children Morning exercise helps calm ADHD symptoms in children
5
Yoga guru BKS Iyengar dies at 95 Yoga guru BKS Iyengar dies at 95
Trending News
Video
x
Feedback